ESRP1在恶性肿瘤中的研究进展

doi:10.16833/j.cnki.jbmc.2022.09.021

摘要/Abstract

摘要： 上皮剪接调节蛋白1(epithelial splicing regulatory protein1,ESRP1)是近年发现的RNA结合蛋白,具有选择性剪接前体mRNA的作用,能够在转录水平调节基因的表达,进而影响基因转录过程。从分子生物学和基因学角度深入研究后发现,ESRP1在多种不同部位的肿瘤中表达情况不一,可能通过信号通路的调控致使恶性肿瘤浸润性、迁移性增强并影响患者预后。ESRP1对肿瘤的起源、进展、转移及预后判断等多方面具有重大意义,本文将围绕ESRP1与恶性肿瘤相关性的研究展开综述,为ESRP1相关的肿瘤诊疗扩展思路。

任伊阳, 王家宏. ESRP1在恶性肿瘤中的研究进展[J]. 包头医学院学报, 2022, 38(9): 92-96.

参考文献

[1] Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2] 李洁,王欢,王斌,等.可变剪接在胃癌中的作用[J].中国细胞生物学学报,2020,42(11):2014-2018.
[3] Brazão TF,Demmers J,van IJcken W,et al.A new function of ROD1 in nonsense-mediated mRNA decay[J].FEBS Lett, 2012,586(8):1101-1110.
[4] 陆欣欣.上皮剪接调节蛋白1(ESRP1)在高级别浆液性卵巢癌中的表达及意义[D].沈阳:中国医科大学,2020.
[5] Wang ZL,Li B,Luo YX,et al.Comprehensive genomic characterization of RNA-binding proteins across human cancers[J].Cell Rep,2018,22(1):286-298.
[6] Gerstberger S,Hafner M,Tuschl T.A census of human RNA-binding proteins[J].Nat Rev Genet, 2014,15(12):829-845.
[7] Preca BT,Bajdak K,Mock K,et al.A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells[J].Int J Cancer,2015,137(11):2566-2577.
[8] Warzecha CC,Sato TK,Nabet B,et al.ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing[J].Mol Cell, 2009,33(5):591-601.
[9] Gökmen-Polar Y,Neelamraju Y,Goswami CP,et al.Splicing factor ESRP1 controls ER-positive breast cancer by altering metabolic pathways[J].EMBO Rep,2019,20(2):e46078.
[10] 周雪梅.TGF-β1、p-AKT在乳腺癌中的表达及其与上皮-间质转化的关系[D].蚌埠:蚌埠医学院,2021.
[11] Pan YH,Zhao YZ,LH,et al.MiR-337-3p suppresses migration and invasion of breast cancer cells by downregulating ESRP1[J].Acta Histochemica,2021,123(7): 151777.
[12] 杨孜欢,冯杏芝,方乐堃,等.长链非编码RNA MALAT1调控Rac1b表达与结直肠癌侵袭和转移的关系[J].中国病理生理杂志,2015,31(8):1417-1421.
[13] 王逸飞,吴欢,薛万国,等.前列腺癌与前列腺增生的分类预测及癌症风险因素分析[J].解放军医学院学报,2021,42(3):277-281,305.
[14] Freytag M,Kluth M,Bady E,et al.Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer[J].BMC Cancer,2020,20(1):1220.
[15] Hanahan D, Weinberg RA.Hallmarks of cancer: the next generation[J].Cell,2011,144(5):646-674.
[16] Fagoonee S, Picco G, Orso F, et al.The RNA-binding protein ESRP1 promotes human colorectal cancer progression[J].Oncotarget,2017,8(6):10007-10024.
[17] 戈瑶,陈玉.miR-23a和ESRP1在直肠癌中的作用[J].现代医学与健康研究电子杂志,2017,1(7):30,56.
[18] 劳玲娟,宋新江,徐佳.miR-23a和ESRP1在直肠癌中的作用[J].中国病理生理杂志,2017,33(5):817-82
[19] Ishii H,Saitoh M,Sakamoto K,et al.Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via different mechanisms[J].J Biol Chem, 2014,289(40):27386-27399.
[20] Ala U,Manco M,Mandili G,et al.Proteomics-based evidence for a pro-oncogenic role of ESRP1 in human colorectal cancer cells[J].Int J Mol Sci,2020,21(2):575.
[21] Desantis CE,Siegel RL,Sauer AG,et al.Cancer statistics for African Americans,2016:progress and opportunities in reducing racial disparities[J].CA Cancer J Clin,2016,66(4):290-308.
[22] Chen L, Yao Y, Sun L, et al.snail driving alternative splicing of CD44 by ESRP1 enhances invasion and migration in epithelial ovarian cancer[J].Cell Physiol Biochem,2017,43(6):2489-2504.
[23] Deng G,Zhou X,Chen L,et al.High expression of ESRP1 regulated by circ-0005585 promotes cell colonization in ovarian cancer[J].Cancer Cell Int,2020,20:174.
[24] Chen S,Wu W,Li QH,et al.Circ-NOLC1 promotes epithelial ovarian cancer tumorigenesis and progression by binding ESRP1 and modulating CDK1 and RhoA expression[J].Cell Death Discov,2021,7(1):22.
[25] Chen ZH,Jing YJ,Yu JB,et al.ESRP1 induces cervical cancer cell G1-phase arrest via regulating cyclin A2 mRNA stability[J].Int J Mol Sci,2019,20(15): 3705.
[26] Ueda J, Matsuda Y, Yamahatsu K, et al.Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases[J].Oncogene, 2014,33(36):4485-4495.
[27] Wu G,Li Z,Jiang P, et al.MicroRNA-23a promotes pancreatic cancer metastasis by targeting epithelial splicing regulator protein 1[J].Oncotarget,2017,8(47):82854-82871.